SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-005904
Filing Date
2019-05-14
Accepted
2019-05-14 16:05:24
Documents
4
Period of Report
2019-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT azrx8k_may2019.htm 8-K 39400
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 100443
3 EXHIBIT 5.1 ex5_1.htm EX-5.1 9737
4 EXHIBIT 10.1 ex10-1.htm EX-10.1 332333
  Complete submission text file 0001654954-19-005904.txt   483175
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 19822684
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1